DNA Clinical Trials

1 recruiting

DNA Trials at a Glance

46 actively recruiting trials for dna are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 12 trials, with the heaviest enrollment activity in Shanghai, Shanghai, and Beijing. Lead sponsors running dna studies include Fudan University, City of Hope Medical Center, and Columbia University.

Browse dna trials by phase

Treatments under study

About DNA Clinical Trials

Looking for clinical trials for DNA? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new DNA trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about DNA clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 46 trials

Recruiting
Not Applicable

Danish Vulva Cancer Recurrence Study

SurvivorshipCirculating Tumor DNAVulvar Cancer+6 more
University of Aarhus1,295 enrolled2 locationsNCT06495554
Recruiting
Phase 2

A Randomized Controlled Trial of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy Decision-Making in High-Risk Stage III (T4N+ or T1-3N2) Colorectal Cancer

ChemotherapyctDNA
Fudan University100 enrolled1 locationNCT07562490
Recruiting
Phase 2

Randomized Trial of Plasma ctDNA Methylation-Guided Adjuvant Therapy in T4N0 and Low-Risk Stage III Colorectal Cancer

ctDNA
Fudan University340 enrolled1 locationNCT07562503
Recruiting
Phase 2

Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal Cancer

ChemotherapyctDNA
Fudan University340 enrolled1 locationNCT07562711
Recruiting
Phase 2

Randomized Controlled Study of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy in Stage I/Low-Risk Stage II Colorectal Cancer

ctDNAColorectal Cancer (CRC)Adjuvant Chemotherapy
Fudan University80 enrolled1 locationNCT07562659
Recruiting

PaCIFiC-CUP Classifies Cancer of Unknown Primary

Unknown Primary TumorsDNA Methylation
Sun Yat-sen University120 enrolled1 locationNCT06140992
Recruiting

NSCLC Liquid Biopsies and Exhaled VOC

Lung CancerCirculating Tumor DNA
St. Joseph's Healthcare Hamilton210 enrolled1 locationNCT06707519
Recruiting

HPV After chemoRadioTherapy

RadiotherapyHPVCervical Cancer Recurrent+1 more
General University Hospital, Prague120 enrolled1 locationNCT07493928
Recruiting
Not Applicable

A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

Esophageal CancerctDNA
The Central Hospital of Lishui City30 enrolled2 locationsNCT06792786
Recruiting
Not Applicable

Pesticides and Infertility: Oxidative Stress Via Circulating Cell-free DNA and Gut/Genital Microbiome Signatures in Women With Endometriosis

InfertilityEndometriosisEpigenetics+7 more
Centre Hospitalier Universitaire, Amiens160 enrolled1 locationNCT07471373
Recruiting
Phase 1Phase 2

EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation

Post-Transplant Lymphoproliferative DisorderEBV-DNA Viremia
Daihong Liu18 enrolled1 locationNCT07438067
Recruiting

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

Mitochondrial DiseasesMitochondrial DisordersMitochondrial Genetic Disorders+2 more
Columbia University1,000 enrolled17 locationsNCT01694940
Recruiting
Phase 2

ctDNA-guided Treatment Decision-making

Metastatic Breast Cancer ( HER2 Negative)ctDNA
Fudan University122 enrolled1 locationNCT07394218
Recruiting
Phase 3

KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

Mitochondrial DiseasesMaternally Inherited Diabetes and Deafness (MIDD)Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)+1 more
Khondrion BV220 enrolled10 locationsNCT06451757
Recruiting

Natural History Study - Mitochondrial Disease

MELAS or m.3243 A>G Mitochondrial DNA Mutation Carrier
Columbia University300 enrolled1 locationNCT01532791
Recruiting
Not Applicable

Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya

Cervical CancerCervical Cancer ScreeningHPV DNA
Kenyatta National Hospital1,980 enrolled1 locationNCT07050745
Recruiting

Feasibility of Circulating Tumour DNA (ctDNA) Analysis Using Automated Capillary Blood Sampling

Colorectal Cancer (Diagnosis)Colorectal Liver Metastasis (CRLM)Circulating Tumor DNA (ctDNA)
Erasmus Medical Center35 enrolled1 locationNCT07310537
Recruiting
Not Applicable

Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer

Breast CancerGynecologic CancerCirculating Tumor DNA+2 more
Poitiers University Hospital1,000 enrolled1 locationNCT04530890
Recruiting

Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)

Metastatic Colorectal Cancer ctDNA Surveillance
Fudan University497 enrolled1 locationNCT07283575
Recruiting
Phase 2

Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures

Dyskeratosis CongenitaFanconi AnemiaBone Marrow Failure+7 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins27 enrolled1 locationNCT04232085